KEGG: sas:SAS1767
To maintain structural and functional integrity of recombinant SAS1767, implement the following evidence-based storage protocol:
| Storage Purpose | Temperature | Duration | Additional Notes |
|---|---|---|---|
| Regular storage | -20°C | Months | In Tris-based buffer with 50% glycerol |
| Extended storage | -80°C | Years | Avoid repeated freeze-thaw cycles |
| Working aliquots | 4°C | Up to one week | For ongoing experiments |
The protein requires storage in an optimized buffer that typically includes 50% glycerol as a cryoprotectant . It is crucial to avoid repeated freeze-thaw cycles, as membrane proteins are particularly susceptible to aggregation and denaturation during temperature fluctuations. Instead, prepare multiple single-use aliquots during initial purification.
A comprehensive experimental design for SAS1767 functional characterization should incorporate multiple complementary approaches:
Gene knockout and complementation studies: Generate SAS1767 deletion mutants and complemented strains to establish phenotypic consequences.
Subcellular localization: Confirm membrane localization through fractionation experiments and immunoblotting with anti-His antibodies (for the recombinant protein).
Protein-protein interaction studies: Implement techniques such as bacterial two-hybrid assays, co-immunoprecipitation, and chemical crosslinking followed by mass spectrometry.
Functional reconstitution: Purify the protein and reconstitute in liposomes to study potential transport or structural functions.
Comparative genomics: Analyze SAS1767 conservation across Staphylococcus strains and related bacteria to infer functional importance.
For experimental design, establish experimental conditions using a mixed-method approach combining both quantitative and qualitative assessment techniques . Document all experimental variables systematically in an Experimental Design Data Set (EDDS) to facilitate rigorous analysis and ensure reproducibility .
To investigate SAS1767 interactions with host immune components, implement this methodological framework:
In silico prediction: Begin with computational prediction of potential immune-interacting regions using epitope prediction algorithms and structural modeling.
Direct binding assays: Use surface plasmon resonance (SPR) or bio-layer interferometry (BLI) to quantify binding kinetics between purified SAS1767 and candidate immune factors.
Cell-based assays: Develop reporter systems in human immune cells to detect SAS1767-triggered signaling events.
Ex vivo exposure experiments: Expose human immune cells to purified SAS1767 and analyze transcriptomic and proteomic changes.
In vivo studies: Compare immune responses to wild-type and SAS1767-deficient S. aureus strains in appropriate animal models.
This multilayered approach aligns with established research methodology principles and enables both identification and validation of immune interactions. When working with recombinant SAS1767, always confirm proper folding through circular dichroism or other biophysical techniques to ensure observed interactions reflect native protein behavior.
Membrane proteins present unique challenges for recombinant expression. Implement this systematic approach:
Construct optimization:
Test multiple expression vectors with different promoter strengths
Evaluate various fusion tags (His, MBP, SUMO) for enhanced solubility
Consider codon optimization for the expression host
Expression host selection:
Compare standard E. coli strains (BL21, C41/C43 specifically designed for membrane proteins)
Evaluate eukaryotic systems for complex membrane proteins
Expression condition optimization matrix:
| Parameter | Variables to Test | Monitoring Method |
|---|---|---|
| Temperature | 16°C, 25°C, 37°C | SDS-PAGE, Western blot |
| Inducer concentration | 0.1-1.0 mM IPTG | Yield quantification |
| Media composition | LB, TB, autoinduction | Growth curves, yield |
| Induction timing | Early, mid, late log phase | Protein quality assessment |
Purification strategy:
Screen multiple detergents for solubilization
Implement two-step purification (IMAC followed by size exclusion)
Test membrane scaffold proteins for nanodiscs
This methodological approach emphasizes systematic parameter optimization with appropriate controls to determine optimal conditions for high-yield, properly-folded SAS1767 production .
When investigating structure-function relationships of SAS1767, implement this statistical analysis framework:
For mutagenesis studies:
Use multiple regression analysis to correlate structural modifications with functional outcomes
Implement ANOVA with post-hoc tests for comparing multiple mutants
Apply non-parametric tests when data don't meet normality assumptions
For biophysical property correlations:
Use principal component analysis (PCA) to identify patterns across multiple parameters
Implement cluster analysis to group functionally similar mutants
Apply machine learning algorithms for complex multivariate relationships
For evolutionary conservation analysis:
Calculate position-specific conservation scores
Perform statistical tests for enrichment of conserved residues in functional regions
Use phylogenetic methods to trace evolutionary importance
The robustness of these analyses depends on proper experimental design documentation, as outlined in the EDDS approach . Ensure sufficient biological and technical replicates (minimum n=3 for each condition) and conduct appropriate power analysis before experiments to determine sample sizes needed for detecting meaningful effects.
Data conflicts are common in membrane protein research due to methodological limitations. Implement this systematic approach to resolve discrepancies:
Methodological evaluation:
Identify inherent limitations of each technique (detection limits, artifacts)
Assess experiment-specific variables that might affect outcomes
Review controls and normalization methods
Biological context analysis:
Consider protein conformational states under different experimental conditions
Evaluate buffer compositions and their effects on protein behavior
Assess potential post-translational modifications
Integrative analysis:
Develop computational models that can accommodate seemingly conflicting data
Weight evidence based on methodological strengths
Identify conditions where results converge
Targeted validation experiments:
Design experiments specifically to address the source of discrepancy
Use orthogonal methods to validate key findings
Implement controlled variable experiments isolating specific parameters
This mixed-method research approach allows for robust data interpretation even when initial results appear contradictory. Document all reconciliation steps thoroughly to ensure reproducibility and transparency in reporting.
Evaluating SAS1767 as a vaccine candidate requires a systematic approach similar to other S. aureus vaccine development efforts:
Antigenicity assessment:
Perform epitope prediction analysis identifying potential B and T cell epitopes
Evaluate surface accessibility and conservation across clinically relevant strains
Analyze potential cross-reactivity with human proteins
Immunogenicity testing:
Test purified SAS1767 with various adjuvants in animal models
Evaluate antibody titers, isotype distribution, and durability
Assess T cell responses through cytokine profiling
Functional antibody assessment:
Protection studies:
Challenge immunized animals with diverse S. aureus strains
Assess bacterial burden, dissemination, and survival rates
Compare with established vaccine candidates
Safety evaluation:
This framework builds on established S. aureus vaccine development pipelines while specifically targeting SAS1767 as a novel antigen, potentially complementing existing vaccine candidates through a multi-antigen approach.
Given the challenges in experimentally determining membrane protein structures, computational approaches provide valuable insights:
Transmembrane domain prediction:
Apply multiple specialized algorithms (TMHMM, HMMTOP, Phobius)
Implement consensus prediction from multiple tools
Validate predictions through limited proteolysis experiments
Homology modeling:
Identify structural homologs through sequence and secondary structure similarity
Build models based on template structures with validation through Ramachandran plots and energy minimization
Refine models using molecular dynamics simulations
Ab initio modeling:
Use fragment-based approaches for regions without homologs
Apply specialized membrane protein folding algorithms
Validate through comparison with experimental data
Molecular dynamics simulations:
Embed predicted structures in simulated lipid bilayers
Assess stability and conformational changes over nanosecond timescales
Identify potential ligand binding sites and functional domains
These computational approaches provide working structural hypotheses that can guide experimental design, particularly for mutagenesis studies targeting predicted functional regions of SAS1767.
Membrane proteins like SAS1767 frequently present solubility challenges. Implement this systematic troubleshooting approach:
Expression optimization:
Reduce expression temperature (16-20°C) to slow folding
Test speciality E. coli strains (C41/C43) designed for membrane proteins
Evaluate co-expression with chaperones
Solubilization strategy optimization:
| Detergent Type | Examples | Optimal for |
|---|---|---|
| Non-ionic | DDM, Triton X-100 | Initial screening |
| Zwitterionic | CHAPS, LDAO | Maintaining activity |
| Steroid-based | Digitonin, GDN | Preserving complexes |
| Polymer-based | SMA, DIBMA | Native lipid retention |
Buffer optimization:
Screen pH ranges (typically 6.5-8.5)
Test stabilizing additives (glycerol, specific lipids)
Evaluate salt concentrations (100-500 mM)
Alternative approaches:
Consider membrane mimetic systems (nanodiscs, liposomes)
Test fusion partners specifically designed for membrane proteins
Evaluate cell-free expression systems
Store purified protein in Tris-based buffer with 50% glycerol at appropriate temperatures as indicated in the product information . Document all optimization steps systematically to establish reproducible protocols for future research.
Structural characterization of membrane proteins requires specialized approaches:
X-ray crystallography optimization:
Screen detergent/lipid combinations systematically
Test in meso crystallization approaches (LCP)
Consider antibody fragment co-crystallization to stabilize structure
Cryo-EM preparation:
Optimize grid preparation (detergent concentration, blotting times)
Screen different support films and grid types
Consider using nanodiscs or amphipols for stability
Alternative structural approaches:
Hydrogen-deuterium exchange mass spectrometry for dynamics
Solid-state NMR for specific structural elements
Cross-linking mass spectrometry for domain organization
Integrative structural biology:
Combine low-resolution experimental data with computational models
Validate structures through functional mutagenesis
Use evolutionary coupling analysis to inform structure
These methodological approaches can overcome the inherent challenges in membrane protein structural biology, providing insights into SAS1767 structure even when high-resolution techniques prove challenging.